These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Immunoinformatics-guided design of an epitope-based vaccine against severe acute respiratory syndrome coronavirus 2 spike glycoprotein. Rakib A; Sami SA; Mimi NJ; Chowdhury MM; Eva TA; Nainu F; Paul A; Shahriar A; Tareq AM; Emon NU; Chakraborty S; Shil S; Mily SJ; Ben Hadda T; Almalki FA; Emran TB Comput Biol Med; 2020 Sep; 124():103967. PubMed ID: 32828069 [TBL] [Abstract][Full Text] [Related]
4. Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach. Bhattacharya M; Sharma AR; Patra P; Ghosh P; Sharma G; Patra BC; Lee SS; Chakraborty C J Med Virol; 2020 Jun; 92(6):618-631. PubMed ID: 32108359 [TBL] [Abstract][Full Text] [Related]
5. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2. Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372 [TBL] [Abstract][Full Text] [Related]
6. Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches. Safavi A; Kefayat A; Mahdevar E; Abiri A; Ghahremani F Vaccine; 2020 Nov; 38(48):7612-7628. PubMed ID: 33082015 [TBL] [Abstract][Full Text] [Related]
7. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2. Lin L; Ting S; Yufei H; Wendong L; Yubo F; Jing Z Virus Res; 2020 Oct; 288():198082. PubMed ID: 32621841 [TBL] [Abstract][Full Text] [Related]
8. Designing Multi-Epitope Vaccines to Combat Emerging Coronavirus Disease 2019 (COVID-19) by Employing Immuno-Informatics Approach. Naz A; Shahid F; Butt TT; Awan FM; Ali A; Malik A Front Immunol; 2020; 11():1663. PubMed ID: 32754160 [TBL] [Abstract][Full Text] [Related]
9. Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach. Ahammad I; Lira SS Int J Biol Macromol; 2020 Nov; 162():820-837. PubMed ID: 32599237 [TBL] [Abstract][Full Text] [Related]
10. Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: A systematic review. Noorimotlagh Z; Karami C; Mirzaee SA; Kaffashian M; Mami S; Azizi M Int Immunopharmacol; 2020 Sep; 86():106738. PubMed ID: 32683296 [TBL] [Abstract][Full Text] [Related]
11. Design of a multi-epitope vaccine against SARS-CoV-2 using immunoinformatics approach. Sanami S; Zandi M; Pourhossein B; Mobini GR; Safaei M; Abed A; Arvejeh PM; Chermahini FA; Alizadeh M Int J Biol Macromol; 2020 Dec; 164():871-883. PubMed ID: 32682041 [TBL] [Abstract][Full Text] [Related]
12. Understanding the B and T cell epitopes of spike protein of severe acute respiratory syndrome coronavirus-2: A computational way to predict the immunogens. Vashi Y; Jagrit V; Kumar S Infect Genet Evol; 2020 Oct; 84():104382. PubMed ID: 32473352 [TBL] [Abstract][Full Text] [Related]
13. Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2. Kalita P; Padhi AK; Zhang KYJ; Tripathi T Microb Pathog; 2020 Aug; 145():104236. PubMed ID: 32376359 [TBL] [Abstract][Full Text] [Related]
14. Epitopes for a 2019-nCoV vaccine. Lucchese G Cell Mol Immunol; 2020 May; 17(5):539-540. PubMed ID: 32094505 [No Abstract] [Full Text] [Related]
15. A candidate multi-epitope vaccine against SARS-CoV-2. Kar T; Narsaria U; Basak S; Deb D; Castiglione F; Mueller DM; Srivastava AP Sci Rep; 2020 Jul; 10(1):10895. PubMed ID: 32616763 [TBL] [Abstract][Full Text] [Related]
16. Epitope-based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: an immune-informatics study. Tahir Ul Qamar M; Saleem S; Ashfaq UA; Bari A; Anwar F; Alqahtani S J Transl Med; 2019 Nov; 17(1):362. PubMed ID: 31703698 [TBL] [Abstract][Full Text] [Related]
17. Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country. Requena D; Médico A; Chacón RD; Ramírez M; Marín-Sánchez O Front Immunol; 2020; 11():2008. PubMed ID: 33013857 [TBL] [Abstract][Full Text] [Related]
18. Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies. Hussain A; Hasan A; Nejadi Babadaei MM; Bloukh SH; Chowdhury MEH; Sharifi M; Haghighat S; Falahati M Biomed Pharmacother; 2020 Oct; 130():110559. PubMed ID: 32768882 [TBL] [Abstract][Full Text] [Related]
19. Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection. Mahapatra SR; Sahoo S; Dehury B; Raina V; Patro S; Misra N; Suar M Expert Rev Vaccines; 2020 Sep; 19(9):871-885. PubMed ID: 32869699 [TBL] [Abstract][Full Text] [Related]
20. The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and Antibodies. Papageorgiou AC; Mohsin I Cells; 2020 Oct; 9(11):. PubMed ID: 33105869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]